Metabolism Disorder TRIZ Cases
- Inhibitory Interneuron Precursors for Hypothalamic Glycemia Control
See how inhibitory interneuron precursors delivered to the hypothalamic arcuate nucleus modulate abnormal neural activity for lasting hyperglycemia reduction.
- RalA Inhibitor Therapy for Obesity and Adipocyte Mitochondrial Function
RalA inhibitors target adipocyte metabolism to increase mitochondrial oxidative phosphorylation and energy expenditure, helping attenuate diet-induced obesity.
- Metabolically Robust Eicosanoid Analogues for GDF-15 Reduction
Limited bioavailability and chemical instability constrain n-3 PUFA metabolites; robust analogues lower GDF-15 levels.
- Momordica Charantia Exosome–mcIRBP Composition for Glucose Lowering
This composition combines Momordica charantia exosomes with mcIRBP to lower blood glucose while addressing severe drug side effects.
- Age-Specific Synthetic Milk Compositions to Reduce Obesity Risk
Conventional infant formula can overfeed older infants, so age-specific compositions tailor protein and caloric density to support growth and reduce obesity risk.
- 2-Pyridone THRβ Agonist Crystal Forms for Stability
A 2-pyridone derivative addresses weak THRβ activity and selectivity through ring changes and crystalline forms with improved stability.
- IGF-2 Peptide Priming for Less Frequent Diabetes Treatment
A 3–7-day IGF-2 priming phase stimulates endogenous insulin production before less frequent dosing for diabetes treatment.
- Ketone Body Compositions for Multi-Factor Lipid Reduction
Ketone body and ester compositions target cholesterol and triglycerides while supporting low-fat dietary compliance and broader vascular risk management.
- Oral Polypeptide Composition with Protease Inhibition for GI Stability
Fish oil, protease inhibitors, and absorption enhancers help protect polypeptides from gastrointestinal degradation for oral delivery.
- Liquid Oxyntomodulin Peptide Analog Formulations for Stability
Learn how pH control, methionine, and sorbitol stabilize liquid oxyntomodulin analogs while reducing impurities during storage.
- IL-4-Derived Peptide Fragments for Nephropathy Inflammation
IL-4-derived peptides address innate inflammation and reduce urinary albumin and KIM-1 in diabetic nephropathy models.
- SLC2A1 lncRNA Regulation for Restoring Brain Glut1 Transport
A natural antisense transcript and rAAV vector raise Glut1 levels across the blood-brain barrier to address seizures and motor dysfunction.
- Selective Anti-Serpin B13 Antibodies for Beta Cell Growth
Selective antibody binding inhibits serpin B13 activity, supporting beta cell proliferation and tissue repair in related disorders.
- AAV Vectors Encoding Modified G6Pase-α for GSD-Ia Deficiency
See how modified G6Pase-α AAV vectors address incomplete hepatic correction in GSD-Ia by increasing enzyme phosphohydrolase activity.